MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific DSO 2011-2026 | TMO
DSO Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70 | 69.9 | 69.6 | 65.4 | 63.8 | 57.2 | 70.8 | 62 | 75.2 | 68.4 | 54.8 | 53.5 | 54.2 | 52.7 | 56.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.2 | 52.7 | 62.9 |
DSO Vierteljährlich Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.8 | 71.7 | 73.6 | 69.7 | 68.7 | 71.9 | 70.7 | 68.1 | 68.3 | - | 32.8 | 32.8 | 61.2 | - | 54 | 54.3 | 52 | - | 61.5 | 75.7 | 73.9 | 58.1 | 63.3 | 62.8 | 63.2 | 58 | 63.8 | 62.1 | 62.5 | 58.5 | 69.2 | 70.9 | 66.3 | 56.2 | 61.9 | 61.3 | 59.4 | 49.9 | 56.3 | 54.4 | 58.4 | 50.2 | 54.1 | 52.2 | 51.6 | 51.1 | 55.5 | 54.7 | 53.6 | 50.5 | 53.4 | 53 | 53.3 | 52.1 | 55.2 | 57.5 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.7 | 32.8 | 59.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
94.7 | $ 5.63 | -2.26 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
50.2 | $ 21.01 | -2.73 % | $ 609 M | USA |
 |
Fulgent Genetics
FLGT
|
87 | $ 19.15 | -1.79 % | $ 589 M | USA |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 125.61 | -5.6 % | $ 15.7 B | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.67 | -6.7 % | $ 7.39 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
66.8 | $ 162.32 | -3.42 % | $ 25.2 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.25 | -3.76 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
63.4 | $ 149.45 | -2.19 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 100.98 | -1.79 % | $ 6.82 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 10.9 | -3.63 % | $ 1.4 B | USA |
 |
Natera
NTRA
|
48.3 | $ 215.31 | -3.06 % | $ 29.4 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 181.34 | -2.4 % | $ 8.99 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
71.8 | $ 1.45 | -11.04 % | $ 435 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 454.25 | -0.97 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 154.33 | -2.22 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
52.3 | $ 4.57 | -2.56 % | $ 423 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 19.14 | -3.09 % | $ 428 M | USA |
 |
Personalis
PSNL
|
63.8 | $ 10.75 | -11.16 % | $ 959 M | USA |
 |
Senseonics Holdings
SENS
|
1.04 | $ 6.67 | -4.85 % | $ 278 M | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.12 | -1.17 % | $ 4.87 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 265.15 | 1.6 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 69.22 | -6.37 % | $ 4.14 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.67 | -2.43 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
306 | $ 365.36 | -2.95 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 8.9 | -2.41 % | $ 1.93 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 200.29 | 2.13 % | $ 22.2 B | USA |